- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Ose Pharma International SA (OSE)
Ose Pharma International SA stock price live, this page displays EPA OSE stock exchange data. View the OSE premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Ose Pharma International SA real time stock price chart below.
What Is the Ose Pharma International SA Stock Price Today?
The Ose Pharma International SA stock price today is 6.75.
What Is the Stock Symbol for Ose Pharma International SA?
The stock symbol for Ose Pharma International SA is "OSE."
What Stock Exchange Does Ose Pharma International SA Trade On?
Ose Pharma International SA is listed and trades on the Paris stock exchange.
Is Ose Pharma International SA a Good Stock to Buy?
Determining whether Ose Pharma International SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OSE quote. (ISIN: FR0012127173)
What Is the Ose Pharma International SA Stock Price Today?
The Ose Pharma International SA stock price today is 6.75.
What Is the Stock Symbol for Ose Pharma International SA?
The stock symbol for Ose Pharma International SA is "OSE."
What Stock Exchange Does Ose Pharma International SA Trade On?
Ose Pharma International SA is listed and trades on the Paris stock exchange.
Is Ose Pharma International SA a Good Stock to Buy?
Determining whether Ose Pharma International SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OSE quote. (ISIN: FR0012127173)
Paris
Currency in EUR
6.75
+0.42(+6.65%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.29
7.00
52 wk Range
4.42
11.58
OSE Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
Unusual trading volume
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.297.00
52 wk Range
4.4211.58
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
OSE Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
16.00
Upside
+137.04%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
- Ose Immuno receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Ose Immuno receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Ose Pharma International SA Company Profile
OSE Immunotherapeutics SA, a clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally. Its products include Tedopi that is in Phase III clinical trial for the treatment of non-small cell lung cancer, as well as in Phase II clinical trial to pancreatic and ovarian cancer; OSE-279, which is in a Phase I/II clinical trial in patients with advanced solid tumors or lymphomas; OSE-127, a humanized monoclonal antibody that is in Phase II clinical trial for the treatment of ulcerative colitis, as well as Sjögren’s Syndrome; and FR104, which is in Phase I clinical trial for the treatment of rheumatoid arthritis. The company is also developing BI 765063, which is in Phase I clinical trial to treat solid tumors; OSE-230, an agonist antibody against ChemR23 to resolve chronic inflammation; CLEC-1, a therapeutic target in immune-oncology and identified monoclonal antibody antagonists; and BiCKI, a novel bispecific checkpoint inhibitor platform that targets PD-1 to fight primary and secondary resistance mechanisms developed by cancers. OSE Immunotherapeutics SA has collaborations and partnerships with GERCOR, ARCAGY-GINECO, Foundation FoRT, and Nantes University Hospital; and Boehringer Ingelheim, MabSilico, CKD, Servier, Veloxis Pharmaceuticals, and Chong Kun Dang Pharmaceutical Corporation. The company was formerly known as OSE Pharma SA and changed its name to OSE Immunotherapeutics SA in May 2016. OSE Immunotherapeutics SA was founded in 2012 and is headquartered in Nantes, France.
Compare OSE to Peers and Sector
Metrics to compare | OSE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOSEPeersSector | |
|---|---|---|---|---|
P/E Ratio | 4.1x | −1.1x | −0.5x | |
PEG Ratio | 0.02 | 0.04 | 0.00 | |
Price/Book | 2.4x | 1.1x | 2.6x | |
Price / LTM Sales | 1.9x | 5.3x | 3.2x | |
Upside (Analyst Target) | 107.4% | 187.5% | 41.2% | |
Fair Value Upside | Unlock | 15.8% | 6.2% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 16.00
(+137.04% Upside)
Earnings
Latest Release
May 01, 2025
EPS / Forecast
-0.90 / --
Revenue / Forecast
862.00K / --
People Also Watch
FAQ
What Is the Ose Pharma International SA (OSE) Stock Price Today?
The Ose Pharma International SA stock price today is 6.75
What Stock Exchange Does Ose Pharma International SA Trade On?
Ose Pharma International SA is listed and trades on the Paris Stock Exchange stock exchange.
What Is the Stock Symbol for Ose Pharma International SA?
The stock symbol for Ose Pharma International SA is "OSE."
What Is the Ose Pharma International SA Market Cap?
As of today, Ose Pharma International SA market cap is 156.64M.
What Is Ose Pharma International SA's Earnings Per Share (TTM)?
The Ose Pharma International SA EPS (TTM) is 1.72.
From a Technical Analysis Perspective, Is OSE a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Ose Pharma International SA Stock Split?
Ose Pharma International SA has split 0 times.
How Many Employees Does Ose Pharma International SA Have?
Ose Pharma International SA has 64 employees.
What is the current trading status of Ose Pharma International SA (OSE)?
As of Jul 29, 2025, Ose Pharma International SA (OSE) is trading at a price of 6.75, with a previous close of 6.32. The stock has fluctuated within a day range of 6.29 to 7.00, while its 52-week range spans from 4.42 to 11.58.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.